Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297201285> ?p ?o ?g. }
- W4297201285 endingPage "508" @default.
- W4297201285 startingPage "497" @default.
- W4297201285 abstract "The study aimed to develop folate decorated lipid chitosan hybrid nanoparticles for targeted delivery of 5-fluorouracil in colon cancer by utilizing the overexpressed folate receptors on the surface of HT-29 and HCT 116 cancer cell lines. The developed formulations were prepared by the ionic gelation method with slight modifications. The developed formulations exhibited spherical morphology, smaller particle size (158 to 225 nm), zeta potential (32.24 to 35.95 mV), PDI (0.19 to 0.35), and high encapsulation efficiency (85.3 % to 94.2 %) with optimal physicochemical characteristics. The in vitro release showed a biphasic release pattern with an initial burst release followed by a sustained release for 48 h. Moreover, the in vitro cell line study revealed that FA-CLPN-2 exhibited an enhanced cellular uptake and greater cytotoxic effect in HT-29 and HCT 116 cell lines compared to non-targeted CLPN-2 and free drug solution due to the folate receptor facilitated endocytosis process. The in vivo toxicity study revealed the safety and biocompatibility of the developed formulations in biological systems. The stability study demonstrates the stability of the developed formulations. Overall, these results suggest that the folate decorated lipid chitosan hybrid nanoparticles could be used as a potential delivery system for tumor-targeted therapy with reduced side effects." @default.
- W4297201285 created "2022-09-27" @default.
- W4297201285 creator A5004295238 @default.
- W4297201285 creator A5005196974 @default.
- W4297201285 creator A5005893683 @default.
- W4297201285 creator A5010652362 @default.
- W4297201285 creator A5010677068 @default.
- W4297201285 creator A5017742392 @default.
- W4297201285 creator A5048751682 @default.
- W4297201285 creator A5057897053 @default.
- W4297201285 creator A5060177855 @default.
- W4297201285 date "2022-12-01" @default.
- W4297201285 modified "2023-10-18" @default.
- W4297201285 title "Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer" @default.
- W4297201285 cites W1973645168 @default.
- W4297201285 cites W1979208912 @default.
- W4297201285 cites W1989229997 @default.
- W4297201285 cites W1995676656 @default.
- W4297201285 cites W2000347606 @default.
- W4297201285 cites W2003090882 @default.
- W4297201285 cites W2003495186 @default.
- W4297201285 cites W2007154517 @default.
- W4297201285 cites W2010845995 @default.
- W4297201285 cites W2029906991 @default.
- W4297201285 cites W2056098467 @default.
- W4297201285 cites W2060103474 @default.
- W4297201285 cites W2087705699 @default.
- W4297201285 cites W2088659772 @default.
- W4297201285 cites W2095335404 @default.
- W4297201285 cites W2187414896 @default.
- W4297201285 cites W2288963150 @default.
- W4297201285 cites W2523940714 @default.
- W4297201285 cites W2559715734 @default.
- W4297201285 cites W2589794204 @default.
- W4297201285 cites W2618916865 @default.
- W4297201285 cites W2737595857 @default.
- W4297201285 cites W2752430299 @default.
- W4297201285 cites W2804731453 @default.
- W4297201285 cites W2808853479 @default.
- W4297201285 cites W2811228980 @default.
- W4297201285 cites W2883849687 @default.
- W4297201285 cites W2890174367 @default.
- W4297201285 cites W2892122806 @default.
- W4297201285 cites W2911165803 @default.
- W4297201285 cites W2914709166 @default.
- W4297201285 cites W2924280186 @default.
- W4297201285 cites W2927629685 @default.
- W4297201285 cites W2948430537 @default.
- W4297201285 cites W2965032633 @default.
- W4297201285 cites W2991337082 @default.
- W4297201285 cites W3007710099 @default.
- W4297201285 cites W3014037184 @default.
- W4297201285 cites W3025274345 @default.
- W4297201285 cites W3038206372 @default.
- W4297201285 cites W3046811749 @default.
- W4297201285 cites W3097409834 @default.
- W4297201285 cites W3116926511 @default.
- W4297201285 cites W3127740703 @default.
- W4297201285 cites W3160415923 @default.
- W4297201285 cites W3194929162 @default.
- W4297201285 cites W3195832040 @default.
- W4297201285 cites W3206893348 @default.
- W4297201285 cites W4200403505 @default.
- W4297201285 cites W4205946057 @default.
- W4297201285 doi "https://doi.org/10.1016/j.ijbiomac.2022.09.196" @default.
- W4297201285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36174854" @default.
- W4297201285 hasPublicationYear "2022" @default.
- W4297201285 type Work @default.
- W4297201285 citedByCount "8" @default.
- W4297201285 countsByYear W42972012852023 @default.
- W4297201285 crossrefType "journal-article" @default.
- W4297201285 hasAuthorship W4297201285A5004295238 @default.
- W4297201285 hasAuthorship W4297201285A5005196974 @default.
- W4297201285 hasAuthorship W4297201285A5005893683 @default.
- W4297201285 hasAuthorship W4297201285A5010652362 @default.
- W4297201285 hasAuthorship W4297201285A5010677068 @default.
- W4297201285 hasAuthorship W4297201285A5017742392 @default.
- W4297201285 hasAuthorship W4297201285A5048751682 @default.
- W4297201285 hasAuthorship W4297201285A5057897053 @default.
- W4297201285 hasAuthorship W4297201285A5060177855 @default.
- W4297201285 hasConcept C121608353 @default.
- W4297201285 hasConcept C12554922 @default.
- W4297201285 hasConcept C1491633281 @default.
- W4297201285 hasConcept C150903083 @default.
- W4297201285 hasConcept C155672457 @default.
- W4297201285 hasConcept C171250308 @default.
- W4297201285 hasConcept C178790620 @default.
- W4297201285 hasConcept C185154212 @default.
- W4297201285 hasConcept C185592680 @default.
- W4297201285 hasConcept C192562407 @default.
- W4297201285 hasConcept C199529486 @default.
- W4297201285 hasConcept C202751555 @default.
- W4297201285 hasConcept C207001950 @default.
- W4297201285 hasConcept C2777230088 @default.
- W4297201285 hasConcept C2779732960 @default.
- W4297201285 hasConcept C2779820397 @default.
- W4297201285 hasConcept C2780306303 @default.
- W4297201285 hasConcept C28005876 @default.